Tag: PRRT

Steve Jobs Bloomberg News

Breaking News: Pancreatic NET Cancer Patient Steve Jobs Steps Down as CEO of Apple

August 24, 2011

On August 24, 2011, Steve Jobs, CEO of Apple, announced that he was stepping down from his position.  In his letter to the Apple Board of Directors and the Apple Community, Mr. Jobs wrote, “I have always said if there ever came a day when I could no longer meet…

READ MORE
Multidisciplinary Team at Bad Berka

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

April 5, 2011

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …

READ MORE
GlucoMedix

RadioMedix $2.8 Million Grant from Texas Emerging Technology Fund to Result in New Products that Benefit Carcinoid and Neuroendocrine Cancer Patients

March 23, 2011

Two innovative products that will enable users to generate and label PET radiotracers on-site at a significantly reduced cost will be developed by RadioMedix, Inc. with a $2.8 million grant from the Texas Emerging Technology Fund.  According to Ebrahim

READ MORE
Staff Sergeant Daniel Barber & Helicopter

A Carcinoid Soldier’s Survivor Story

October 1, 2010

When Staff Sergeant Daniel Barber of D Company 1-106th AVN in the Missouri National Guard was first diagnosed with carcinoid cancer in 2009 he experienced feelings of shock, despair, anger, fear and frustration.  But he was also relieved because he knew…

READ MORE
Laurie Todd Photo

New Message for Carcinoid Patients from “The Insurance Warrior”

February 28, 2010

 

Laurie Todd, “The Insurance Warrior,” has a special message for the carcinoid community.

The Carcinoid Cancer Foundation is delighted to partner with Laurie to bring you cutting-edge information about how to fight your insurance… READ MORE